Abicon Max (500 mg+213 mg+325 mg)/10 ml (Oral Suspension)
200 ml bottle: ৳ 300.00
Medicine Details
Category | Details |
---|---|
Generic | Sodium alginate sodium bicarbonate calcium carbonate |
Company | Healthcare pharmaceuticals ltd |
Also available as |
Title
Abicon Max 500 Suspension
Categories
- Medicine
- Antacids
- Gastric Health
Description
Abicon Max is a combination of two antacids (Calcium carbonate and Sodium bicarbonate) and an alginate (Sodium alginate). It is indicated for gastric reflux, heartburn, indigestion, flatulence associated with gastric reflux, heartburn of pregnancy, and all cases of epigastric and retrosternal distress where the underlying cause is gastric reflux.
Attributes
- Indications:
- Gastric reflux
- Heartburn
- Indigestion
- Flatulence associated with gastric reflux
- Heartburn of pregnancy
- Epigastric and retrosternal distress
- Pharmacology:
- Combination of two antacids (Calcium carbonate and Sodium bicarbonate) and an alginate (Sodium alginate)
- Neutralizes excess stomach acid to relieve pain & discomfort
- Forms a protective barrier over the stomach contents to soothe burning pain in the chest
- Physical mode of action, not dependent on absorption into the systemic circulation
- Rapid reaction with gastric acid to form a raft of Alginic Acid gel with near neutral pH
- Interacts with and caps the acid pocket in the stomach, reducing esophageal acid exposure
- Floats on stomach contents, impeding gastro-esophageal reflux for up to 4 hours
- Protects the esophagus from acid, pepsin, and bile
- May exert a demulcent effect in severe cases
- Dosage & Administration:
- Oral suspension for adults and children over 12 years: 10-20 mL after meals and at bedtime, up to four times a day
- Chewable tablet for adults and children over 12 years: two to four tablets after meals and at bedtime, up to four times a day
- No recommended dosage for children under 6 years
- No dose modifications for the elderly
- Hepatic impairment: No dose modification necessary
- Renal insufficiency: Caution if highly restricted salt diet is necessary
- Interaction:
- Consider 2-hour time interval between Abicon Max intake and administration of other medicinal products
- Avoid concurrent use with specific drugs such as Tetracyclines, Digoxin, Fluoroquinolones, Iron salts, etc.
- Contraindications:
- Known or suspected hypersensitivity to the active ingredients or excipients
- Side Effects:
- Constipation
- Flatulence
- Stomach cramps
- Belching
- Sensation of swelling with big doses
- Pregnancy & Lactation:
- Safe for use during pregnancy if clinically needed
- No effects shown in breastfed infants
- No negative effect on parental or offspring fertility or reproduction
- Precautions & Warnings:
- Each 20 mL dose contains 254.5 mg of sodium
- Care needed in treating patients with hypercalcemia, nephrocalcinosis, and recurrent calcium-containing renal calculi
- Not recommended for children under 12 years except on medical advice
- High in sodium and calcium content
- Not recommended for patients with phenylketonuria due to aspartame content
- Seek medical advice if symptoms persist or treatment is required for more than 7 days continuously
- Can mask symptoms of other serious underlying medical conditions
- Overdose Effects:
- Symptomatic treatment in case of overdose
- Abdominal distension may occur
- Therapeutic Class:
- Antacids
- Storage Conditions:
- Store in a cool (below 30°C) and dry place, away from light
- Do not refrigerate or freeze
- Common Questions:
- Abicon Max 500 Suspension is the combination of two antacids and an alginate, commonly used to treat Gastric reflux, Heartburn, Indigestion, Flatulence associated with gastric reflux
- Safe to use during pregnancy and breastfeeding
Related Brands
- Gaviflux DX (500 mg+213 mg+325 mg)/10 ml (Oral Suspension) - beacon-pharmaceuticals-plc
- Gavisilk (500 mg+267 mg+160 mg)/10 ml (Oral Suspension) - the-white-horse-pharmaceuticals-ltd
- Xeliscon DX (500 mg+213 mg+325 mg)/10 ml (Oral Suspension) - osl-pharma-limited
- Gaviflux 250 mg+133.5 mg+80 mg (Chewable Tablet) - beacon-pharmaceuticals-plc
- Gaviraft (500 mg+213 mg+325 mg)/10 ml (Oral Suspension) - nuvista-pharma-ltd